{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T20:31:03Z","timestamp":1785184263218,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972667"],"award-info":[{"award-number":["81972667"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2701103"],"award-info":[{"award-number":["2021YFC2701103"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013285","name":"Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning","doi-asserted-by":"publisher","award":["TP2018046"],"award-info":[{"award-number":["TP2018046"]}],"id":[{"id":"10.13039\/501100013285","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014175","name":"Shanghai Municipal Health and Family Planning Commission","doi-asserted-by":"publisher","award":["20194Y0281"],"award-info":[{"award-number":["20194Y0281"]}],"id":[{"id":"10.13039\/501100014175","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014175","name":"Shanghai Municipal Health and Family Planning Commission","doi-asserted-by":"publisher","award":["202140224"],"award-info":[{"award-number":["202140224"]}],"id":[{"id":"10.13039\/501100014175","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.bbrc.2023.04.008","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T05:47:46Z","timestamp":1681451266000},"page":"75-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Selamectin increases cisplatin sensitivity by inhibiting cisplatin-resistant genes expression and autophagy in uveal melanoma"],"prefix":"10.1016","volume":"661","author":[{"given":"Jie","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jili","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9779-6225","authenticated-orcid":false,"given":"Jianfeng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2023.04.008_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133094","article-title":"Recent advances and challenges in uveal melanoma immunotherapy","volume":"14","author":"Fu","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bbrc.2023.04.008_bib2","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1101\/gad.296962.117","article-title":"Focus on cutaneous and uveal melanoma specificities","volume":"31","author":"Pandiani","year":"2017","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbrc.2023.04.008_bib3","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.ophtha.2012.01.048","article-title":"Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patients","volume":"119","author":"Damato","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.bbrc.2023.04.008_bib4","first-page":"11","article-title":"Tebentafusp: T cell redirection for the treatment of metastatic uveal melanoma","author":"Damato","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.bbrc.2023.04.008_bib5","series-title":"Molecular Characteristics of Uveal Melanoma: Insights from the Cancer Genome Atlas","first-page":"11","author":"Bakhoum","year":"2019"},{"key":"10.1016\/j.bbrc.2023.04.008_bib6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","article-title":"Uveal melanoma","volume":"6","author":"Jager","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.bbrc.2023.04.008_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00008390-200506000-00010","article-title":"Phase II trial of cisplatin, gemcitabine and treosulfan in patients with metastatic uveal melanoma","volume":"15","author":"Schmittel","year":"2005","journal-title":"Melanoma Res."},{"key":"10.1016\/j.bbrc.2023.04.008_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.critrevonc.2016.03.014","article-title":"Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies","volume":"102","author":"Ho","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbrc.2023.04.008_bib9","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2023.04.008_bib10","first-page":"E4777","article-title":"Cisplatin-DNA adduct repair of transcribed genes is controlled by two circadian programs in mouse tissues","volume":"115","author":"Yang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2023.04.008_bib11","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1200\/JCO.2009.23.6018","article-title":"Ultimate fate of oncology drugs approved by the us food and drug administration without a randomized Trial","volume":"27","author":"Tsimberidou","year":"2009","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.bbrc.2023.04.008_bib12","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1073\/pnas.1011379108","article-title":"Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in\u00a0vivo","volume":"108","author":"Dhar","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2023.04.008_bib13","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1158\/1541-7786.MCR-22-0111","article-title":"Combinatorial treatment with PARP-1 inhibitors and cisplatin attenuates cervical cancer growth through fos-driven changes in gene expression","volume":"20","author":"Gupte","year":"2022","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbrc.2023.04.008_bib14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13046-022-02345-x","article-title":"Inhibition of carbonic anhydrases IX\/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion","volume":"41","author":"Sarnella","year":"2022","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2023.04.008_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22967","article-title":"Reversal of cisplatin resistance by neferine\/isoliensinine and their combinatorial regimens with cisplatin-induced apoptosis in cisplatin-resistant colon cancer stem cells (CSCs)","volume":"36","author":"Manogaran","year":"2022","journal-title":"J.\u00a0Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bbrc.2023.04.008_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/08923973.2022.2112219","article-title":"Monensin synergizes with chemotherapy in uveal melanoma through suppressing RhoA","volume":"45","author":"Zeng","year":"2023","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.bbrc.2023.04.008_bib17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2020.05.040","article-title":"A\u00a0genetic map of the response to DNA damage in human cells","volume":"182","author":"Olivieri","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2023.04.008_bib18","doi-asserted-by":"crossref","first-page":"6395","DOI":"10.1038\/s41388-021-02055-2","article-title":"A\u00a0highly annotated database of genes associated with platinum resistance in cancer","volume":"40","author":"Huang","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2023.04.008_bib19","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1158\/1078-0432.CCR-13-1131","article-title":"The PDGFRbeta-AKT pathway contributes to CDDP-acquired resistance in testicular germ cell tumors","volume":"20","author":"Juliachs","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2023.04.008_bib20","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1158\/1078-0432.CCR-15-1275","article-title":"Adrenergic stimulation of DUSP1 impairs chemotherapy response in ovarian cancer","volume":"22","author":"Kang","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2023.04.008_bib21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ccell.2018.06.012","article-title":"MAST1 drives cisplatin resistance in human cancers by rewiring cRaf-independent MEK activation","volume":"34","author":"Jin","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2023.04.008_bib22","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1038\/s41388-018-0238-8","article-title":"Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance","volume":"37","author":"Zhou","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2023.04.008_bib23","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s10637-020-01032-y","article-title":"Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer","volume":"39","author":"Gasiorkiewicz","year":"2021","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.bbrc.2023.04.008_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102925","article-title":"Cisplatin: the first metal based anticancer drug","volume":"88","author":"Ghosh","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbrc.2023.04.008_bib25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0959-437X(02)00282-4","article-title":"Histone H2A variants H2AX and H2AZ","volume":"12","author":"Redon","year":"2002","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.bbrc.2023.04.008_bib26","doi-asserted-by":"crossref","first-page":"13949","DOI":"10.1073\/pnas.240464697","article-title":"Drug-resistant Drosophila indicate glutamate-gated chloride channels are targets for the antiparasitics nodulisporic acid and ivermectin","volume":"97","author":"Kane","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2023.04.008_bib27","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1158\/1535-7163.MCT-14-0980-T","article-title":"Selective inhibition of SIN3 corepressor with avermectins as a novel therapeutic strategy in triple-negative breast cancer","volume":"14","author":"Kwon","year":"2015","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.bbrc.2023.04.008_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104763","article-title":"Inhibition of TMEM16A Ca(2+)-activated Cl(-) channels by avermectins is essential for their anticancer effects","volume":"156","author":"Zhang","year":"2020","journal-title":"Pharmacol. Res."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23004096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23004096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:55:46Z","timestamp":1767966946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X23004096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":28,"alternative-id":["S0006291X23004096"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.04.008","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selamectin increases cisplatin sensitivity by inhibiting cisplatin-resistant genes expression and autophagy in uveal melanoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}